Summary
87.99
0.78
(0.89%)
04/13/2026
Medtronic plc (MDT)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years |
| 0.89 | 1.08 | -2.19 | -9.31 | -7.21 | 9.01 | -16.59 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan!
Fundamental Ratings
| Category | Rating |
| Main Rating | B+ |
| Recommended Rating | Neutral |
| DCF | Buy |
| ROE | Neutral |
| ROA | Strong Buy |
| Debt/Equity | Strong Sell |
| P/E | Sell |
| P/B | Neutral |
Earnings
| Trading Data | ||
| Close | 87.99 | |
| Open | 87.00 | |
| High | 88.14 | |
| Low | 86.41 | |
| Volume | 6,106,715 | |
| Change | 0.78 | |
| Change % | 0.89 | |
| Avg Volume (20 Days) | 7,945,510 | |
| Volume/Avg Volume (20 Days) Ratio | 0.77 | |
| 52 Week Range | 77.47 - 104.70 | |
| Price vs 52 Week High | -15.96% | |
| Price vs 52 Week Low | 13.57% | |
| Range | -1.29 | |
| Gap Up/Down | -0.20 | |
Profitibility | ||
| Market Capitalization (Mln) | 118,276 | |
| Revenue per share | 27.6765 | |
| Net Income per share | 3.5988 | |
| Dividend Yield | 0.0326 | |
| Dividend Share | 284.00% | |
Valuations | ||
| Enterprise Value | 0.00% | |
| PE Ratio | 24.2332 | |
| PB Ratio | 0.0000 | |
| PTB Ratio | 0.0000 | |
Liquidity | ||
| Debt/Equity Ratio | 0.0000 | |
| Net Debt/EBIDTA Ratio | 0.0000 | |
| Current Ratio | 0.0000 | |
Enterprise Value and Cash Flow | ||
| EV/Sales Ratio | 0.0000 | |
| EV/EBIDTA Ratio | 0.0000 | |
| EV/Free Cash Flow Ratio | 0.0000 | |
04/13 06:00 EST - prnewswire.com
Medtronic to announce financial results for its fourth quarter and full fiscal year 2026
GALWAY, Ireland, April 13, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Wednesday, June 3, 2026, for its fourth quarter and full fiscal year 2026, which ends on Friday, April 24, 2026. A news...
Medtronic to announce financial results for its fourth quarter and full fiscal year 2026
GALWAY, Ireland, April 13, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Wednesday, June 3, 2026, for its fourth quarter and full fiscal year 2026, which ends on Friday, April 24, 2026. A news...
04/09 09:00 EST - businesswire.com
GE HealthCare announces digital integration between bkActiv™ intraoperative ultrasound system and Medtronic Stealth AXiS™ surgical navigation system
CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced a digital integration between the GE HealthCare bkActiv™ intraoperative ultrasound (iUS) system and the Medtronic Stealth AXiS™ surgical navigation system, which is now commercially available to provide real-time advanced imaging during...
GE HealthCare announces digital integration between bkActiv™ intraoperative ultrasound system and Medtronic Stealth AXiS™ surgical navigation system
CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced a digital integration between the GE HealthCare bkActiv™ intraoperative ultrasound (iUS) system and the Medtronic Stealth AXiS™ surgical navigation system, which is now commercially available to provide real-time advanced imaging during...
04/08 18:51 EST - zacks.com
Medtronic (MDT) Beats Stock Market Upswing: What Investors Need to Know
In the latest trading session, Medtronic (MDT) closed at $88.65, marking a +2.58% move from the previous day.
Medtronic (MDT) Beats Stock Market Upswing: What Investors Need to Know
In the latest trading session, Medtronic (MDT) closed at $88.65, marking a +2.58% move from the previous day.
04/08 10:15 EST - fool.com
3 Dividend Stocks to Double Up On Right Now
From energy to healthcare, this trio of reliable dividend payers are worth a deep dive today.
3 Dividend Stocks to Double Up On Right Now
From energy to healthcare, this trio of reliable dividend payers are worth a deep dive today.
04/06 05:43 EST - defenseworld.net
Medtronic PLC $MDT Position Lifted by Savvy Advisors Inc.
Savvy Advisors Inc. grew its stake in shares of Medtronic PLC (NYSE: MDT) by 85.4% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,777 shares of the medical technology company's...
Medtronic PLC $MDT Position Lifted by Savvy Advisors Inc.
Savvy Advisors Inc. grew its stake in shares of Medtronic PLC (NYSE: MDT) by 85.4% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,777 shares of the medical technology company's...
04/06 02:02 EST - defenseworld.net
Contrasting Omeros (NASDAQ:OMER) and Medtronic (NYSE:MDT)
Medtronic (NYSE: MDT - Get Free Report) and Omeros (NASDAQ: OMER - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, profitability, analyst recommendations,...
Contrasting Omeros (NASDAQ:OMER) and Medtronic (NYSE:MDT)
Medtronic (NYSE: MDT - Get Free Report) and Omeros (NASDAQ: OMER - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, profitability, analyst recommendations,...
04/06 01:09 EST - defenseworld.net
MacroGenics (NASDAQ:MGNX) & Medtronic (NYSE:MDT) Critical Review
Medtronic (NYSE: MDT - Get Free Report) and MacroGenics (NASDAQ: MGNX - Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk and...
MacroGenics (NASDAQ:MGNX) & Medtronic (NYSE:MDT) Critical Review
Medtronic (NYSE: MDT - Get Free Report) and MacroGenics (NASDAQ: MGNX - Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk and...
04/05 06:46 EST - defenseworld.net
Stratos Wealth Partners LTD. Reduces Stock Holdings in Medtronic PLC $MDT
Stratos Wealth Partners LTD. cut its stake in shares of Medtronic PLC (NYSE: MDT) by 9.1% during the undefined quarter, according to its most recent filing with the SEC. The institutional investor owned 74,371 shares of the medical technology company's stock after selling 7,442 shares during the...
Stratos Wealth Partners LTD. Reduces Stock Holdings in Medtronic PLC $MDT
Stratos Wealth Partners LTD. cut its stake in shares of Medtronic PLC (NYSE: MDT) by 9.1% during the undefined quarter, according to its most recent filing with the SEC. The institutional investor owned 74,371 shares of the medical technology company's stock after selling 7,442 shares during the...
04/02 10:47 EST - proactiveinvestors.com
A new valve, a new playbook: How Anteris is trying to reshape a $10B heart market
Cardiovascular disease may be one of medicine’s oldest battlegrounds, but some of its most important technologies are still evolving — and not always as...
A new valve, a new playbook: How Anteris is trying to reshape a $10B heart market
Cardiovascular disease may be one of medicine’s oldest battlegrounds, but some of its most important technologies are still evolving — and not always as...
04/02 09:29 EST - proactiveinvestors.com
Tilray Brands’ strong cannabis sales and upbeat outlook keeps Jefferies analysts bullish
Tilray Inc (NASDAQ:TLRY) earned a repeat ‘Buy’ rating from Jefferies analysts after what it described as a solid third quarter earnings report, pointing to...
Tilray Brands’ strong cannabis sales and upbeat outlook keeps Jefferies analysts bullish
Tilray Inc (NASDAQ:TLRY) earned a repeat ‘Buy’ rating from Jefferies analysts after what it described as a solid third quarter earnings report, pointing to...
04/02 09:12 EST - proactiveinvestors.com
GLP-1 wars: Lilly's FDA-approved oral weight-loss pill puts Novo Nordisk's Wegovy franchise under fresh pressure
Foundayo launches on April 6 at the same price as Novo's pill, threatening to reshape the $50 billion obesity drug market before Novo's first-quarter...
GLP-1 wars: Lilly's FDA-approved oral weight-loss pill puts Novo Nordisk's Wegovy franchise under fresh pressure
Foundayo launches on April 6 at the same price as Novo's pill, threatening to reshape the $50 billion obesity drug market before Novo's first-quarter...
04/02 07:10 EST - proactiveinvestors.com
Smart automation bots and the future of forex trading
The forex market now turns over $9.6 trillion every single day. That figure, confirmed by the Bank for International Settlements in its 2025 Triennial...
Smart automation bots and the future of forex trading
The forex market now turns over $9.6 trillion every single day. That figure, confirmed by the Bank for International Settlements in its 2025 Triennial...
04/01 09:31 EST - zacks.com
MDT Stock May Gain From FDA's Nod for Stealth AXiS Surgical System
Medtronic wins FDA's approval for Stealth AXiS in cranial & ENT, expanding its AI-driven surgical platform after spine clearance and boosting growth prospects.
MDT Stock May Gain From FDA's Nod for Stealth AXiS Surgical System
Medtronic wins FDA's approval for Stealth AXiS in cranial & ENT, expanding its AI-driven surgical platform after spine clearance and boosting growth prospects.
04/01 08:30 EST - businesswire.com
Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced results from the ALERT (Addressing undertreatment and heaLth Equity in aortic stenosis and mitral regurgitation using an integrated ehR plaTform)...
Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced results from the ALERT (Addressing undertreatment and heaLth Equity in aortic stenosis and mitral regurgitation using an integrated ehR plaTform)...
03/30 18:51 EST - zacks.com
Medtronic (MDT) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Medtronic (MDT) concluded the recent trading session at $85.74, signifying a -1.61% move from its prior day's close.
Medtronic (MDT) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Medtronic (MDT) concluded the recent trading session at $85.74, signifying a -1.61% move from its prior day's close.
03/27 11:07 EST - seekingalpha.com
Medtronic: Time For A Growth Spurt
Medtronic plc is a stable medical device company currently trading below analyst price targets and undervalued, presenting a potential short-term value opportunity. GLP-1 drugs may not materially threaten MDT; patient discontinuation rates and new surgical eligibility could offset potential...
Medtronic: Time For A Growth Spurt
Medtronic plc is a stable medical device company currently trading below analyst price targets and undervalued, presenting a potential short-term value opportunity. GLP-1 drugs may not materially threaten MDT; patient discontinuation rates and new surgical eligibility could offset potential...
03/27 09:00 EST - prnewswire.com
Medtronic Receives FDA Clearance for Stealth AXiS™ Surgical System for Cranial and ENT Procedures
GALWAY, Ireland, March 27, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) clearance of the Stealth AXiS™ surgical system for cranial and ear, nose, and throat (ENT) procedures. Cleared for spine...
Medtronic Receives FDA Clearance for Stealth AXiS™ Surgical System for Cranial and ENT Procedures
GALWAY, Ireland, March 27, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) clearance of the Stealth AXiS™ surgical system for cranial and ear, nose, and throat (ENT) procedures. Cleared for spine...
03/26 05:15 EST - defenseworld.net
Czech National Bank Increases Stake in Medtronic PLC $MDT
Czech National Bank boosted its stake in shares of Medtronic PLC (NYSE: MDT) by 3.9% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 338,206 shares of the medical technology company's stock after purchasing...
Czech National Bank Increases Stake in Medtronic PLC $MDT
Czech National Bank boosted its stake in shares of Medtronic PLC (NYSE: MDT) by 3.9% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 338,206 shares of the medical technology company's stock after purchasing...
03/25 10:46 EST - zacks.com
MDT Expands Agreement With Merit to Offer ViaVerte: Stock to Gain?
Medtronic expands its pain portfolio with a new ViaVerte BVNA system deal with Merit, aiming to tap rising demand for minimally invasive chronic pain treatments.
MDT Expands Agreement With Merit to Offer ViaVerte: Stock to Gain?
Medtronic expands its pain portfolio with a new ViaVerte BVNA system deal with Merit, aiming to tap rising demand for minimally invasive chronic pain treatments.
Market News
×
Loading news…